• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Incyte Corporation (INCY)

    -NasdaqGS
    85.85 Down 1.69(1.93%) Feb 27, 4:00PM EST
    |After Hours : 85.85 0.00 (0.00%) Feb 27, 4:25PM EST
    Add to Portfolio
    Prev Close:87.54
    Open:87.01
    Bid:N/A
    Ask:108.30 x 100
    1y Target Est:91.08
    Beta:0.02
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:84.23 - 87.60
    52wk Range:40.30 - 88.44
    Volume:917,065
    Avg Vol (3m):1,151,100
    Market Cap:14.75B
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INCYDown 1.93%14.75B
    AMGNDown 0.79%119.69B
    CELGDown 1.48%97.30B
    RHHBYUp 0.80%N/A

    Key Statistics

    Forward P/E (1 yr):85.00
    P/S (ttm):29.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.25
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-4.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback